The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.514
Bid: 1.518
Ask: 1.528
Change: 0.002 (0.13%)
Spread: 0.01 (0.659%)
Open: 1.52
High: 1.53
Low: 1.51
Prev. Close: 1.512
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CIB Q1-2023 Separate Financial Statements

15 May 2023 07:00

RNS Number : 3364Z
Commercial Intnl Bank (Egypt) SAE
14 May 2023
 

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/3364Z_1-2023-5-14.pdfCommercial International Bank (Egypt) S.A.E.

Condensed Separate Interim Financial Statements

March 31, 2023

 

 

Condensed Separate Interim Statement of Financial Position as at March 31, 2023

 

Notes

Mar. 31, 2023

 

Dec. 31, 2022

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

Assets

 

 

 

 

Cash and balances at the central bank

8

52,319,656

 

47,384,574

 

Due from banks

9

169,608,129

 

133,766,196

 

Loans and advances to banks, net

11

616,088

 

2,978,197

 

Loans and advances to customers, net

12

212,026,712

 

192,621,288

 

Derivative financial instruments

 

2,087,218

 

1,939,961

 

Investments

 

 

 

- Financial Assets at Fair Value through OCI

13

184,988,891

 

202,916,225

 

- Financial Assets at Amortized cost

13

43,228,737

 

34,178,753

 

- Investments in associates and subsidiaries

14

2,116,344

 

1,074,250

 

Noncurrent assets held for sale

27

159,828

 

-

 

Other assets

15

14,686,237

 

14,454,868

 

Deferred tax assets

 

-

 

24,240

 

Property and equipment

16

2,357,699

 

2,304,513

 

Total assets

 

684,195,539

 

633,643,065

 

Liabilities and equity

 

 

 

Liabilities

 

 

 

Due to banks

17

8,286,858

 

3,475,848

 

Due to customers

18

574,113,802

 

530,124,905

 

Derivative financial instruments

 

8,294

 

219,752

 

Deferred tax liabilities

303,511

 

-

 

Current income tax liabilities

1,991,935

 

3,051,583

 

Other liabilities

19

16,012,509

 

11,549,472

 

Issued debt instruments

20

3,069,231

 

2,456,607

 

Other loans

 

9,586,379

 

7,978,975

 

Other provisions

21

8,699,209

 

7,065,292

 

Total liabilities

 

622,071,728

 

565,922,434

 

Equity

 

 

 

 

Issued and paid up capital

 

29,990,563

 

29,825,134

 

Reserves

 

24,012,537

 

19,502,716

 

Reserve for employee stock ownership plan (ESOP)

 

1,667,377

 

1,895,435

 

Retained earnings *

 

6,453,334

 

16,497,346

 

Total equity and net profit for the period / year

 

62,123,811

 

67,720,631

 

Total liabilities and equity

 

684,195,539

 

633,643,065

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

(Limited review report attached)

Including net profit for the current period

 

 

 

 

 

 

Hussein Abaza

Hisham Ezz Al-Arab

 

CEO & Managing Director

Chairman

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Income Statement for the period ended March 31, 2023

 

 

 

 

 

 

 

 

 

Notes

 

Mar. 31, 2023

 

Mar. 31, 2022

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

Interest and similar income

19,729,848

 

11,812,196

 

Interest and similar expense

(8,897,778)

 

(5,209,537)

 

Net interest income

10,832,070

 

6,602,659

 

 

 

 

 

Fee and commission income

2,004,350

 

1,191,476

 

Fee and commission expense

(792,102)

 

(514,635)

 

Net fee and commission income

 

 

1,212,248

 

676,841

 

 

 

 

 

Dividend income

32,362

 

37,800

 

Net trading income

5

 

1,845,604

 

716,066

 

Profits (Losses) on financial investments

13

 

70,920

 

1,021,334

 

Administrative expenses

 

(2,004,617)

 

(1,545,348)

 

Other operating (expenses) income

6

(1,969,625)

 

(1,425,498)

 

Impairment release (charges) for credit losses

 

 

(947,656)

 

40,525

 

Profit before income tax

 

9,071,306

 

6,124,379

 

 

 

 

 

Income tax expense

25

(2,264,671)

 

(1,375,213)

 

Deferred tax assets (Liabilities)

25

(722,182)

 

(509,574)

 

Net profit for the period

 

6,084,453

 

4,239,592

 

 

 

 

 

Earning per share

7

 

 

 

Basic

1.81

 

1.26

 

Diluted

1.79

 

1.24

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

CEO & Managing Director

 

Hisham Ezz El-Arab

 

Chairman

 

 

 

 

 

Condensed Separate Interim Statement of Comprehensive Income for the period ended March 31, 2023

 

 

 

 

 

 

 

 

 

 

 

Mar. 31, 2023

 

Mar. 31, 2022

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

Net profit for the period

6,084,453

 

4,239,592

 

Change in fair value of Financial investments measured at fair value through comprehensive income after tax

(8,507,038)

 

(3,958,945)

 

Transferred to RE from financial assets at fair value through comprehensive income

(1,895)

 

(4,201)

 

Effect of ECL in fair value of debt instruments measured at fair value through comprehensive income

208,250

 

101,561

 

Total comprehensive income for the period

(2,216,230)

 

378,007

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Cash flows for the period ended March 31 2023

 

 

 

 

 

 

 

 

 

Notes

Mar. 31, 2023

 

Mar. 31, 2022

EGP Thousands

 

EGP Thousands

 

 

Cash flow from operating activities

 

 

Profit before income tax

9,071,306

 

6,124,379

Adjustments to reconcile profits to net cash provided by operating activities

 

 

Fixed assets depreciation

 

16

206,400

 

210,105

Impairment (Released) charge for credit losses (Loans and advances to customers and banks)

 

 

714,714

 

(147,259)

Other provisions charges

 

21

464,368

 

1,036,307

Impairment (Released) charge for credit losses (due from banks)

 

 

(1,549)

 

4,977

Impairment (Released) charge for credit losses (financial investments)

234,491

 

101,757

Impairment (Released) charge for other assets

-

 

(277,768)

Exchange revaluation differences for financial assets at fair value through OCI and AC

(6,033,831)

 

63

Utilization of other provisions

21

(345)

 

(156)

Other provisions no longer used

 

21

-

 

(385)

Exchange differences of other provisions

 

21

1,169,894

 

278,463

profits from selling property and equipment

 

 

(118)

 

(50)

profits from selling financial investments at fair value through OCI

 

13

(70,920)

 

(1,021,334)

Shares based payments

 

 

190,974

 

175,235

Operating profits before changes in operating assets and liabilities

 

5,945,384

 

6,484,334

 

 

 

Net decrease (increase) in assets and liabilities

 

 

Due from banks

12,102,385

 

25,542,432

Financial assets at fair value through P&L

-

 

239,339

Derivative financial instruments

 

(358,715)

 

(680,290)

Loans and advances to banks and customers

 

11 - 12

(17,757,613)

 

(12,715,125)

Other assets

 

 

(75,936)

 

1,851,768

Due to banks

 

17

4,811,010

 

2,833,129

Due to customers

 

18

43,988,897

 

21,553,142

Current income tax obligations paid

 

 

(272,736)

 

(261,790)

Other liabilities

 

(362,831)

 

1,876,780

Net cash generated from (used in) operating activities

 

48,019,845

 

46,723,719

 

 

 

 

 

Cash flow from investing activities

 

 

Payments for investment in subsidiaries

(1,216,022)

 

-

Payment for purchases of property, equipment and branches constructions

(415,435)

 

(76,753)

Proceeds from selling property and equipment

 

118

 

50

Proceeds from redemption of financial assets at amortized cost

 

196,783

 

2,609,283

Payment for purchases of financial assets at amortized cost

(8,454,232)

 

(2,430,124)

Payment for purchases of financial assets at fair value through OCI

(32,426,908)

 

(68,194,467)

Proceeds from selling financial assets at fair value through OCI

46,782,676

 

78,071,439

Net cash generated from (used in) investing activities

4,466,980

 

9,979,428

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Cash flows for the period ended March 31, 2023 (Cont.)

 

 

 

 

Mar. 31, 2023

 

Mar. 31, 2022

 

EGP Thousands

 

EGP Thousands

 

 

 

 

Cash flow from financing activities

 

 

 

Other loans

 

1,607,404

 

1,035,994

 

Dividends paid

 

(1,964,603)

 

(4,410,322)

 

Issued debt instruments

612,624

 

253,338

 

Capital increase

165,429

 

122,716

 

Net cash generated from (used in) financing activities

420,854

 

(2,998,274)

 

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalent during the period

52,907,679

 

53,704,873

 

Beginning balance of cash and cash equivalent

92,895,143

 

60,891,899

 

Cash and cash equivalent at the end of the period

145,802,822

 

114,596,772

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

Cash and balances at the central bank

 

52,319,656

 

30,471,454

 

Due from banks

 

169,655,814

 

120,943,837

 

Treasury bills and other governmental notes

10

68,681,151

 

40,371,415

 

Obligatory reserve balance with CBE

 

(45,888,981)

 

(26,030,335)

 

Due from banks with maturities more than three months

 

(29,664,721)

 

(10,245,456)

 

Treasury bills with maturity more than three months

(69,300,097)

 

(40,914,143)

 

Total cash and cash equivalent

145,802,822

 

114,596,772

 

 

 

 

 

 

 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended March 31, 2022

 

Mar. 31, 2022

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

EGP Thousands

Beginning balance

19,702,418

3,293,074

28,260,532

1,549,445

16,000

639,231

9,141

13,783,935

1,674,392

68,928,168

Capital increase

122,716

-

502,922

-

-

-

-

-

(502,922)

122,716

Transferred to reserves

-

670,872

8,333,404

-

2,947

-

-

(9,007,223)

-

-

Dividend paid

-

-

-

-

-

-

-

(4,410,322)

-

(4,410,322)

Net profit of the period

-

-

-

-

-

-

-

4,239,592

-

4,239,592

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

(4,201)

-

4,201

-

-

Net unrealized gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

(3,958,945)

-

-

-

(3,958,945)

Transferred (from) to bank risk reserve

-

-

-

-

-

-

2,840

(2,840)

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

101,561

-

-

-

101,561

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

175,235

175,235

Ending balance

19,825,134

3,963,946

37,096,858

1,549,445

18,947

(3,222,354)

11,981

4,607,343

1,346,705

65,198,005

 

 

 

 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended March 31, 2023

 

 

 

 

Mar. 31, 2023

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

EGP Thousands

Beginning balance

29,825,134

3,963,946

27,096,858

1,549,445

18,947

(13,138,461)

11,981

16,497,346

1,895,435

67,720,631

 

 

Capital increase

165,429

-

-

-

-

-

-

-

-

165,429

 

 

Transferred to reserves

-

806,408

11,998,639

-

2,208

-

-

 (12,388,223)

(419,032)

-

 

 

Dividend paid

-

-

-

-

-

-

-

(3,738,888)

-

(3,738,888)

 

 

Net profit of the period

-

-

-

-

-

-

-

6,084,453

-

6,084,453

 

 

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

(1,895)

-

1,895

-

-

 

 

Net unrealized gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

(8,507,038)

-

-

-

(8,507,038)

 

 

Transferred (from) to banking risk reserve

-

-

-

-

-

-

3,249

(3,249)

-

-

 

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

208,250

-

-

-

208,250

 

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

190,974

190,974

 

 

Ending balance of the period

29,990,563

4,770,354

39,095,497

1,549,445

21,155

(21,439,144)

15,230

6,453,334

1,667,377

62,123,811

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFAIMFTMTIBBFJ
Date   Source Headline
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
20th Feb 20247:00 amRNSNotice of AGM
20th Feb 20247:00 amRNSInvitation to Extraordinary GM (EGM)
16th Nov 20233:45 pmRNSCIB secures a USD 150M subordinated loan from EBRD
3rd Nov 20237:05 amRNS3Q23 Earnings Release
3rd Nov 20237:05 amRNS3rd Quarter Results
3rd Nov 20237:05 amRNS3rd Quarter Results - Consolidated
23rd Aug 20237:14 amRNSAppointment of Mr. Jawaid Mirza in CIB's BOD
24th Jul 20238:00 amRNSCIB 1H2023 Earnings Release
24th Jul 20238:00 amRNSCIB1H2023 Condensed Consolidated Financials
24th Jul 20238:00 amRNSCIB 1H2023 Separate Condensed Financial Statements
10th Jul 20238:00 amRNSCIB obtaining Long term loans from IFC
15th May 20237:00 amRNSCIB 1Q23 - Earnings Release
15th May 20237:00 amRNSCIB Q1-2023 Separate Financial Statements
15th May 20237:00 amRNSCIB 1Q23 Consolidated Financial Statements
20th Mar 20236:26 pmRNSCIB's FY22 IFRS 9 Financial Statements
20th Mar 20235:02 pmRNSResolutions Extraordinary General Assembly
20th Mar 20234:55 pmRNSResolutions Ordinary General Assembly (OGM)
16th Feb 20237:00 amRNSInvitation to CIB's Ordinary General Assembly
16th Feb 20237:00 amRNSInvitation to CIB's Extraordinary General Assembly
13th Feb 20237:00 amRNSCIB - 4Q 2022 Earnings Release
13th Feb 20237:00 amRNSCIB Q4-2022 Separate Financial Statements
13th Feb 20237:00 amRNSCIB Q4-2022 Consolidated Financial Statements
30th Jan 20237:00 amRNSCIB fully acquires MayFair CIB (Kenya)-Replacement
27th Jan 20235:51 pmRNSCIB fully acquires Mayfair CIB
11th Jan 20234:41 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension
8th Dec 202212:25 pmRNSPress Release dated 8 December 2022
22nd Nov 20228:14 amRNSChanges in CIB's Board of Directors
4th Nov 20227:00 amRNS3rd Quarter 2022 (Earnings Release)
4th Nov 20227:00 amRNSBoard Resolutions Summary 3 Nov 2022
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Separate)
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Consolidated)
15th Aug 20227:00 amRNSChange in CIB's CEO Retail Banking
25th Jul 20227:00 amRNSCIB 1H2022 Condensed Separate Financial Results
25th Jul 20227:00 amRNSCIB1H2022 Earnings Release
25th Jul 20227:00 amRNSCIB1H2022 Consolidated Condensed Financial Results
19th May 20223:09 pmRNSChange in CIB's Board of Directors
29th Apr 202212:17 pmRNSCIB FY 2021 IFRS Annual Financial Report
19th Apr 20227:00 amRNSCIB 1Q2022 Earnings Release
19th Apr 20227:00 amRNSCIB1Q2022 Condensed Consolidated Financial results
19th Apr 20227:00 amRNSCIB 1Q2022 Condensed Separate Results
28th Mar 20227:00 amRNSCIB's AGM Resolutions Summary
10th Mar 20224:41 pmRNSSecond Price Monitoring Extn
10th Mar 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSInvitation toCIB Ordinary General Assembly Meeting
22nd Feb 20227:00 amRNSCIB FY 2021 Separate Financial results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.